1-5 of 5
Roy Vitkon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted, Low Cost Epigenetic Microarray for AML and MDS Detection

Miriam Neaman, Mika Bell, Jasline Deek, Rita Haldar, Amit Manor, Yakir Moshe, Irit Mazza Avivi, Moshe Mittelman, Roy Vitkon, Mor Levi, Roi Gat, Gil Fridberg, Natalia Birov, Guoda Daukėlaitė, Karolis Sablauskas, Andrejus Černovas, Andrius Zucenka, Vilmantė Vaitekėnaitė, Efstathios Kastritis, Tomas Papajik, Eva Kriegova, Martin Cernan, Tereza Dyskova, Yuval Ebenstein
Journal: Blood
Blood (2024) 144 (Supplement 1): 6142.
https://doi.org/10.1182/blood-2024-208540
Published: 2024
Journal Articles

Epcoritamab for Relapsed/Refractory B Cell Lymphoma - the Israeli Real-World Experience of a Compassionate Use Program

Shlomzion Aumann, Abraham Avigdor, Ronit Marcus, Netanel A. Horowitz, Ronit Gurion, Tamar Tadmor, Roy Vitkon, May Meira Basood, Uri Abadi, Meirav Kedmi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5124.
https://doi.org/10.1182/blood-2024-198926
Published: 2024
Journal Articles

Detection of B Cell Lymphomas By a Simple Epigenetic Blood Test

Irit Mazza Avivi, Miriam Neaman, Noa Lowenton-Spier, Chava Perry, Erel Joffe, Roy Vitkon, Vlada Bogol, Yael Michaeli, Noa Gilat, Lynne Itelson, Shahar Zirkin, Jasline Deek, Efstathios Kastritis, Karolis Sablauskas, Skirmante Cernauskiene, Vilmantė Vaitekėnaitė, Andrius Zucenka, Tomas Papajik, Eva Kriegova, Petr Gajdos, Yuval Ebenstein
Journal: Blood
Blood (2024) 144 (Supplement 1): 1582.
https://doi.org/10.1182/blood-2024-207707
Published: 2024
Journal Articles

Outcomes of Acute Myeloid Leukemia Patients Suffering from an Additional Active Malignancy Treated with Venetoclax and Azacitidine: A Single Center Experience

Yakir Moshe, Shai Levi, Miriam Neaman, Roi Gat, Mor Levi, Nili Eilati, Gil Fridberg, Yotam Bornstein, Tamir Shragai, Tsipora Neuman, Roy Vitkon, Eliya Shachar, David Sarid, Ofer Merimsky, Moshe Mittelman, Irit Avivi Mazza
Journal: Blood
Blood (2023) 142 (Supplement 1): 5929.
https://doi.org/10.1182/blood-2023-186234
Published: 2023
Journal Articles

Time to Progression Post-Induction Predicts Outcomes of Ixazomib Based Therapy for Relapsed/Refractory Myeloma: Real World Data from a Multi-Site Israeli Registry Study

Yael C Cohen, Hila Magen, MD, Noa Lavi, MD, Moshe E. Gatt, MD, Evgeni Chubar, MD, Natalia Kreiniz, Tamar Tadmor, MD, Svetlana Trestman, MD, Roy Vitkon, MD, Ory Rouvio, Olga Shvetz, MD, Adir Shaulov, MD, Irit Avivi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1972.
https://doi.org/10.1182/blood-2018-99-114217
Published: 2018